<!DOCTYPE html>
<html>

	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">

		<title>FAHZU News</title>
		<script src="js/jquery-1.9.1.min.js" type="text/javascript"></script>
		<link href="css/bootstrap.min.css" rel="stylesheet">
		<script src="js/bootstrap.min.js" type="text/javascript"></script>
		<link href="css/englishstyle.css" rel="stylesheet">
		<script src="js/front.js" type="text/javascript"></script>
		<script src="js/banner.js"></script>
		<link href="css/banner.css" rel="stylesheet">
		<!-- 新闻轮播 -->
		<link rel="stylesheet" type="text/css" href="css/newstyles4.css">
		<script type="text/javascript" src="js/jq142.js"></script>
		<script type="text/javascript" src="js/2011home_cm.js"></script>

		<!-- vedio -->
		<script src="js/jquery.jplayer280.js" type="text/javascript"></script>
		<script src="js/vedio280.js" type="text/javascript"></script>
		<link href="css/jplayer.blue.monday280.css" rel="stylesheet" type="text/css">
		<!-- vedio -->

		<script src="js/rolljs.js"></script>
		<link href="css/jzlbtp.css" rel="stylesheet">

		<style>
			a.jp-video-play-icon {
				position: absolute;
				display: block;
				width: 72px;
				height: 72px;
				margin-left: -36px;
				margin-top: -50px;
				left: 50%;
				top: 50%;
				background: url("img/tv.png") 0 0 no-repeat;
				text-indent: -9999px;
			}
			
			div.jp-video div.jp-volume-bar {
				top: 8px;
				left: 65px;
			}
		</style>
		<script src="js/eshouye.js"></script>
	</head>

	<body>
		<div class="bodyall">
			<div class="eheader">
				<div style="float: left;"><img src="img/eheadimg.jpg"></div>
				<div class="elang">
					<a>Chinese</a>&nbsp;&nbsp;|&nbsp;&nbsp;
					<a >English</a>
				</div>
				<div class="eheadermulu">
					<a href="index.html"><span>Home</span></a>
					<a href="overview.html"><span>Overview</span></a>
					<a href="patientcare.html"><span>Patient Care</span></a>
					<a href="research.html"><span>Research</span></a>
					<a href="intelCop.html" style="width:200px;"><span style="width:200px;">International Cooperation</span></a>
				</div>
			</div>

			<div class="ebody">
				<script type="text/javascript" src="js/patientcaremenu.js"></script>

				<div class="eleftmulu">
					<a id="zygwdh329" href="fazunewslist.html" class="current">FAHZU News</a>
					<a id="zygwdh330" href="g20newslist.html">G20 Special</a>
				</div>

				<div class="erightnr">
				<div class="erighttop">Home / FAHZU News </div>
				<div class="emain article">
					<h3>Forum discusses immunology, blood-related diseases</h3>
                    <!-- <div class= "meta singlemeta" >
                    <$[发布时间]>begin
                           <span> Date Issued： 2016-04-27 11:36:30</span >
                           <$[发布时间]>end &nbsp;
                           <$[信息作者]>begin
                           <span> Writer：
                           </span>
                           <$[信息作者]>end
                           &nbsp;
                           <$[信息来源]>begin
                           <span> Article From：  </span >
                           <$[信息来源]>end
                           <span> Pageviews：<span id="views"></span > </span >
                    </div> -->
					<p></p><p>A forum gathered a galaxy of senior medical experts in Hangzhou, east China's Zhejiang Province from Friday through Sunday to share the latest findings about immunology and blood-related diseases.</p>
<p>At the meeting, academicians Chen Saijuan, Ruan Changgeng and Cao Xuetao of the Chinese Academy of Engineering and Professor Qing Yi from the Cleveland Clinic of the United States made reports of "great academic significance", said other experts attending the forum.</p>
<p>Many other renowned specialists from home and abroad also made reports to elaborate on the frontier researches of the immunological science and treatment of diseases in the blood system.</p>
<p>The forum, which is called a summit of immunological and hematological experts, was sponsored by the Chinese Association of Pathophysiology in cooperation with the Zhejiang Society for Immunology, and was hosted by Zhejiang University, the owner of the FAHZU.</p>
<p>Topics of discussion during the two-day forum include the latest findings in the study of the relationship between malignant tumors in the blood system and factors like the immune cells, chemokines, bone marrow microenvironment and the resistance mechanism.</p>
<p>Many younger scholars also conducted heated discussions about the diagnosis and treatment of the peripheral T cell lymphomas, primary central nerve system lymphomas (PCNSL), amyloidosis, and POEMS syndrome, which is a rare blood disorder that damages nerves and affects many other parts of the body.</p>
<p>Paying great attention to the rising of MDT (multiple disciplinary treatment), the forum also features the participation of experts from other disciplines such as nephrology, rheumatoid immune epidemiology, blood transfusion and so on. These experts shared their experiences in the treatment of kidney damage of multiple myeloma and anti-phospholipid syndrome,among other conditions.</p>
<p>The forum also made a systematic discussion about sub-disciplines and the building of MDT model.&nbsp;</p>
<p></p>
					
				</div>
			</div>
			</div>
			<div class="efooter">
				<div style="float: left;"><img src="img/efootimg.jpg"></div>
				<div class="efootright">
					<div class="efootmulu">
						<a >Home</a>|
						<a href="overview.html">Overview</a>|
						<a href="patientcare.html">Patient Care</a>|
						<a href="research.html">Research</a>|
						<a >Web Managerment</a>
					</div>
					<div class="efooternr">
						网站故障联系电话：(0571)87236648&nbsp;&nbsp; 浙ICP备05058494号&nbsp;&nbsp; 设计制作：杭州卓健信息科技有限公司&nbsp;

					</div>
				</div>
			</div>
		</div>

	</body>

</html>